Ifp Advisors, Inc Affimed N.V. Transaction History

Ifp Advisors, Inc

  • $2.05 Billion
  • Q4 2023

A detailed history of Ifp Advisors, Inc transactions in Affimed N.V. stock. As of the latest transaction made, Ifp Advisors, Inc holds 1,150 shares of AFMD stock, worth $6,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,150
Previous 1,150 -0.0%
Holding current value
$6,221
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 06, 2022
BUY
$2.27 - $4.86 $2,610 - $5,589
1,150 New
1,150 $2,000
Q2 2022

Aug 12, 2022
SELL
$2.27 - $4.86 $2,610 - $5,589
-1,150 Closed
0 $0
Q2 2021

Jul 13, 2021
BUY
$7.78 - $11.4 $8,947 - $13,110
1,150 New
1,150 $10,000

Others Institutions Holding AFMD

# of Institutions
4
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $808M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email